Forskning
Udskriv Udskriv
Switch language
Hvidovre Hospital - en del af Københavns Universitetshospital
Udgivet

Development and validation of an instrument to measure the impact of genetic testing on self-concept in Lynch syndrome

Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  1. Clinical and molecular delineation of PUS3-associated neurodevelopmental disorders

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  • M J Esplen
  • N Stuckless
  • S Gallinger
  • M Aronson
  • H Rothenmund
  • K Semotiuk
  • J Stokes
  • C Way
  • J Green
  • K Butler
  • H V Petersen
  • J Wong
Vis graf over relationer
Esplen MJ, Stuckless N, Gallinger S, Aronson M, Rothenmund H, Semotiuk K, Stokes J, Way C, Green J, Butler K, Petersen HV, Wong J. Development and validation of an instrument to measure the impact of genetic testing on self-concept in Lynch syndrome. A positive genetic test result may impact on a person's self-concept and affect quality of life. The purpose of the study was to develop a self-concept scale to measure such impact for individuals carrying mutations for a heritable colorectal cancer Lynch syndrome (LS). Two distinct phases were involved: Phase 1 generated specific colorectal self-concept candidate scale items from interviews with eight LS carriers and five genetic counselors, which were added to a previously developed self-concept scale for BRCA1/2 mutation carriers, Phase II had 115 LS carriers complete the candidate scale and a battery of validating measures. A 20-item scale was developed with two dimensions identified through factor analysis: stigma/vulnerability and bowel symptom-related anxiety. The scale showed excellent reliability (Cronbach's α = 0.93), good convergent validity by a high correlation with impact of event scale (r(102) = 0.55, p <0.001) and Rosenberg self-esteem scale (r(108) = -0.59, p <0.001), and a low correlation with the Fear questionnaire (r(108) = 0.37, p <0.001). The scale's performance was stable across participant characteristics. This new scale for measuring self-concept has potential to be used as a clinical tool and as a measure for future studies.
OriginalsprogEngelsk
TidsskriftClinical Genetics
Vol/bind80
Udgave nummer5
Sider (fra-til)415-423
Antal sider9
ISSN0009-9163
DOI
StatusUdgivet - nov. 2011

ID: 34693441